Hybridan Small Cap Feast: 25/04/2024
* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced
Dish of the day
Admissions:
Delistings:
Smart Metering Systems (SMS.L) has delisted from the AIM market
What’s baking in the oven? **
Potential**** Initial Public Offerings:
Reverse Takeovers:
16 April 2024: Concurrent with its Admission to trading on AIM, Electric Guitar is proposing to acquire the entire issued share capital of 3radical Limited for a consideration of approximately £1.3m, payable by the issue of new ordinary shares in Electric Guitar. The Acquisition constitutes a reverse takeover under the Listing Rules and therefore shareholder approval for the Acquisition is being sought at a general meeting of Electric Guitar to be convened for 1 May 2024.
17 April 2024: TGI Fridays, Inc. (TGIF) announces that it has reached agreement on a non-binding basis for a proposed all-share acquisition of TGI Fridays, Inc. The Proposed Transaction would result in existing Hostmore shareholders holding 36% of the enlarged business upon completion (the Combined Group), with TGI Fridays shareholders holding a 64% shareholding. TGI Fridays is expected to be purchased for an enterprise value of £177m, or approximately 5.4x its FY23 underlying EBITDA. The Combined Group is expected to be renamed TGI Fridays plc, with its shares admitted to trading on the LSE’s Main Market. Completion of the Proposed Transaction expected to be by the end of Q3 2024.
Change of Market:
8 April 2024: a multi-channel value retailers of books, arts and crafts, stationery, toys and games, offering customers a differentiated proposition as a value alternative to full price specialist retailers. The Company is listed on the premium segment of the Main market of the London Stock Exchange. The Company has announced its intention to change to the AIM market on 3 May 2024. Currently the market capitalisation of TheWorks is £16m.
Dual Listing:
23 April 2024: Wellnex Life Limited (ASX:WNX), an Australian consumer healthcare Company, has commenced the process to dual list on the LSE. The Company believes that a dual listing will increase its international profile, particularly in Europe where Wellnex has an existing supply agreement with Haleon into the UK. Currently, the market capitalisation of Wellnex is AUD$23.8m.
Banquet Buffet***
4500p £124.6m (CAM.L)
The Agriculture focused Company announces that Susan Walker, Chief Financial Officer has indicated her intention not to stand for re-election as CFO and director at the forthcoming AGM which is expected to be held on 6 June 2024. The Company announces the appointment of Oliver Capon as the new CFO. Oliver is an experienced and commercial CFO with thirty years of experience.
22p £23.8m (CKT.L)
The augmented workflow and smart sensor automation Company for frontline workers announces its audited final results for the year ended 31 January 2024. Revenue increased 17% to £12m (2023: £10.3m), the loss before tax reduced to £4.6m (2023: (£12m) and net cash reduced to £9m (2023: £15.6m). Trading since the start of the new financial year has seen continued momentum in line with the Board's and market expectations. The Company continues to execute against the growth strategy and develop technology, while progressing on the path to profitability.
0.36p £6.7m (CRCL.L)
The pan Angolan/Brazilian focused exploration and production Company announces Scott Gilbert will be interim CEO with immediate effect and joining the Board as an Executive Director. Mr. Gilbert, who has been acting as a consultant to the Company developing opportunities in both Brazil and Angola, brings with him 15 years of experience in the oil & gas sector. Ms. Jennifer Ayers will no longer be joining the board, but will remain as the Company's Exploration Director.
14.5p £13.8m (DEST.L)
The clinical stage innovative biotechnology Company focused on the development of novel medicines that can prevent life threatening infections announces its audited financial results for the year ended 31 December 2023. The loss before tax reduced to £6.4m (2022: £7.7m), year-end cash and cash equivalents was £6.4m (2022: £4.9m). The Company today provides an update regarding licencing for XF-73 nasal. The Company has engaged with a number of potential partners and has received some strong and positive feedback on XF-73 nasal. However, no potential licencing deal has, to date, been forthcoming that we believe would provide fair value to the Company and its shareholders.
33p £56.1m (HRN.L)
The international models and collectibles Company today announces the following changes to the Board of Directors of Hornby. For personal, health related, reasons Lyndon Davies will formally step down from his position as Non-Executive Chairman on 30 April 2024 and continue to serve on the Board as a Non-Executive Director. At this point, John Stansfield, an existing Independent Non-Executive Director, and past Chairman of Hornby PLC, will step into the role as Interim Independent Non-Executive Chairman while the search for an Independent Non-Executive Chairman is underway.
9.5p £6.4m (NBB.L)
The Executive Search and Interim Management firm announces a trading update for the quarter ended 31 March 2024. Net Fee Income came in at £2.15m, down 12% against a record breaking Q1 2023 and 47% up on Q1 2022 (£1.46m). Five additional fee earners are starting in Q2 & Q3 2024, covering Digital and Technology, Investor Practice (PE/ VC), Life Sciences and Industrial (Energy and Aviation).
38.5p £34.4m (SKL.L)
The provider of SaaS compliance platforms and off-the-shelf e-learning announces its audited results for the twelve months ended 31 December 2023. Revenue increased 15% to £11.3m (2022: £9.8m), LBITDA increased £0.6m (2022: £0.3m), whilst the cash decreased 6% to £7.2m (2022: £7.7m). Skillcast entered the new financial year in a good financial and operational position. Recent product enhancements and new go-to-market strategy have increased enquiry levels from potential customers, which the Company is working to convert into additional subscription revenues.
20p £22.7m (S247.L)
The provider of AI-enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients announces that it has signed a new contract with a large banking and insurance organisation, worth EUR 720k over three years. The contract encompasses both Smarttech247's VisionX Managed Detection and Response capability as well as its customised governance, risk, and compliance services. Smarttech247 will offer its client round-the-clock monitoring and rapid incident response, information security and risk capabilities, as well as data loss prevention solutions to ensure regulatory compliance and protection against imminent cyber threats.
108.5p £31.9m (VNET.L)
The provider of actionable data and business insight through our ecosystem of connected hardware devices, management software platforms, and business insights portal announces a notable strategic contract win with Wilcomatic Wash Systems, the UK's leading provider of commercial vehicle wash systems for petrol forecourts. Vianet and its key partner Suresite Group Ltd, the forecourt retail payment specialists, have strengthened their presence in the UK Car wash and Valeting market by securing the rollout of their contactless payment solution on a 5-year agreement with Wilcomatic.
77.5p £17.6m (ZIN.L)
The television and content production Group announces its audited results for the year ended 31 December 2023. Revenue increased 34% to £40.2m (2022: £30.1m), an Adjusted EBITDA of £1.0m (2022: £0.1m) was reported, and there was a cash balance of £4.9m (2022: £3.6m). The Group is trading strongly with £24m of revenue already booked and expected to be recognised in FY24.
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.